Vaccine maker Novavax is waiting for its COVID-19 vaccine to be approved in the U.K., and is hopeful that U.S. approval will follow. NPR's Steve Inskeep speaks to Novavax CEO Stanley Erck.
Subscribe to:
Post Comments
(
Atom
)
Post a Comment